During this webinar, Dr. William Tap will discuss newly approved treatment options as well as clinical trials for advanced GIST. Dr. Tap will explain how each of these drugs works to target mutations and when they are used for targeted treatment. A Q&A session will follow this presentation.
About the Presenter
Dr. William D. Tap
Chief, Sarcoma Medical Oncology Service
Memorial Sloan Kettering Cancer Center
Dr. Tap is the Chief of the Sarcoma Medical Oncology Service at Memorial Sloan Kettering Cancer Center in New York. Bill has extensive experience in translational medicine and is currently in charge of the clinical, basic science, and translational aspects of the Sarcoma Medical Oncology Program at MSKCC. He is also helping to develop a comprehensive Adolescent and Young Adult Caner Program at MSKCC. Bill received his Medical Degree from Jefferson Medical College in Philadelphia, PA and performed his residency in Internal Medicine at the Vanderbilt University Medical Center in Nashville, TN and his fellowship in Hematology and Medical Oncology at the UCLA Medical Center in Los Angeles, CA. Bill also has a tremendous interest in global health care initiatives and effecting health disparities in underserved areas in the US and abroad.
